Literature DB >> 25226516

Symptoms of Anxiety and Depression Are Associated With Satisfaction With Information Provision and Internet Use Among 3080 Cancer Survivors: Results of the PROFILES Registry.

Nienke Beekers1, Olga Husson, Floortje Mols, Mies van Eenbergen, Lonneke V van de Poll-Franse.   

Abstract

BACKGROUND: Dissatisfaction with information provided by healthcare providers may be a reason for cancer survivors to seek health information on the Internet and may also result in more symptoms of anxiety and depression among this population.
OBJECTIVE: The aim of this study was to investigate whether anxious and depressive symptoms are associated with satisfaction with information provision and Internet use among cancer survivors.
METHODS: All individuals diagnosed with endometrial or colorectal cancer between 1998 and 2007 or lymphoma or multiple myeloma between 1999 and 2008 as registered in the Eindhoven Cancer Registry were invited for participation. In total, 4 446 survivors received a questionnaire including the 25-item European Organisation for Research and Treatment of Cancer Quality of Life Group Information questionnaire and Hospital Anxiety and Depression Scale; 69% responded (n = 3080).
RESULTS: Having anxious (odds ratio [OR], 0.7; 95% confidence interval [CI], 0.5-0.9; P < .05) or depressive symptoms (OR, 0.5; 95% CI, 0.4-0.7; P < .001), or both (OR, 0.4; 95% CI, 0.4-0.7; P < .001) were negatively associated with experienced helpfulness of the received information. Having depressive symptoms or having both depressive and anxious symptoms were negatively associated with satisfaction with information (OR, 0.5; 95% CI, 0.4-0.7; OR, 0.5; 95% CI, 0.4-0.7, respectively; P < .001). Having depressive symptoms was negatively associated with disease-related Internet use (OR, 0.69; 95% CI, 0.5-0.9; P < .05).
CONCLUSION: The results may indicate that information provision is suboptimal, either because it is not adjusted to the mental health status of cancer patients or because it is unsatisfactory and thereby causing anxious and depressive symptoms among cancer patients. IMPLICATIONS FOR PRACTICE: More attention should be paid to optimally adjust the information provision to the individual needs of the cancer patients for better mental health.

Entities:  

Mesh:

Year:  2015        PMID: 25226516     DOI: 10.1097/NCC.0000000000000184

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  5 in total

1.  Optimal cancer care: what essential elements of care would help haematological cancer patients obtain and understand information about their disease and its treatment and impact?

Authors:  Jamie Bryant; Rochelle Smits; Heidi Turon; Rob Sanson-Fisher; Jennifer Engel
Journal:  Support Care Cancer       Date:  2018-03-09       Impact factor: 3.603

2.  Factors Associated with Meeting the Psychosocial Needs of Cancer Survivors in Nova Scotia, Canada.

Authors:  Soleil Chahine; Gordon Walsh; Robin Urquhart
Journal:  Curr Oncol       Date:  2020-11-30       Impact factor: 3.677

3.  Impact of a web-based prostate cancer treatment decision aid on patient-reported decision process parameters: results from the Prostate Cancer Patient Centered Care trial.

Authors:  Maarten Cuypers; Romy E D Lamers; Paul J M Kil; Lonneke V van de Poll-Franse; Marieke de Vries
Journal:  Support Care Cancer       Date:  2018-05-12       Impact factor: 3.603

4.  To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?

Authors:  S L Herbert; A Wöckel; R Kreienberg; T Kühn; F Flock; R Felberbaum; W Janni; C Curtaz; M Kiesel; T Stüber; J Diessner; J Salmen; L Schwentner; V Fink; I Bekes; E Leinert; K Lato; A Polasik; F Schochter; S Singer
Journal:  Breast Cancer Res Treat       Date:  2020-10-26       Impact factor: 4.872

5.  Impact of health-related stigma on psychosocial functioning in cancer patients: Construct validity of the stigma-related social problems scale.

Authors:  Emma Ohlsson-Nevo; Johan Ahlgren; Jan Karlsson
Journal:  Eur J Cancer Care (Engl)       Date:  2020-08-31       Impact factor: 2.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.